A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C
2014 ◽
Vol 74
(3)
◽
pp. 626-627
◽
2003 ◽
Vol 62
(11)
◽
pp. 1078-1082
◽
2009 ◽
Vol 30
(7)
◽
pp. 977-978
◽
2015 ◽
Vol 75
(10)
◽
pp. 1757-1762
◽
2004 ◽
Vol 16
(8)
◽
pp. 761-765
◽
2019 ◽
Vol 44
(3)
◽
pp. 269-276
◽
2006 ◽
Vol 9
(2)
◽
pp. 170-174
◽